CARM

Carisma Therapeutics (CARM)

Carisma Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CARM

<< 이전 1 2 3 4 5

일자	시간	출처	헤드라인	심볼	기업
2023/06/06	00:45	Business Wire	Carmila: Information concerning the total number of voting rights and share, provided pursuant to article L.233-8 II of the Code de commerce (French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des marchés financiers	NASDAQ:CARM	Carisma Therapeutics Inc
2023/06/05	20:30	PR Newswire (US)	Carisma Therapeutics to Present at Upcoming Investor Conferences in June 2023	NASDAQ:CARM	Carisma Therapeutics Inc
2023/05/31	05:30	PR Newswire (US)	Carisma Therapeutics to Present at Upcoming Healthcare Industry Conferences in June 2023	NASDAQ:CARM	Carisma Therapeutics Inc
2023/05/11	20:30	PR Newswire (US)	Carisma Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Highlights	NASDAQ:CARM	Carisma Therapeutics Inc
2023/05/09	05:30	PR Newswire (US)	Carisma Therapeutics to Present at the JMP Securities Life Sciences Conference	NASDAQ:CARM	Carisma Therapeutics Inc
2023/05/06	05:30	PR Newswire (US)	Carisma Therapeutics to Present at Upcoming Healthcare Industry Conferences in May 2023	NASDAQ:CARM	Carisma Therapeutics Inc
2023/05/04	00:45	Business Wire	Carmila: Information concerning the total number of voting rights and share, provided pursuant to article L.233-8 II of the Code de commerce (French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des marchés financiers	NASDAQ:CARM	Carisma Therapeutics Inc
2023/05/04	00:45	Business Wire	Carmila : Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L.233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des marchés financiers	NASDAQ:CARM	Carisma Therapeutics Inc
2023/04/21	00:55	Business Wire	Carmila: First-quarter 2023 Financial Information	NASDAQ:CARM	Carisma Therapeutics Inc
2023/04/21	00:55	Business Wire	Carmila : Information financière au 31 mars 2023	NASDAQ:CARM	Carisma Therapeutics Inc
2023/04/20	22:22	Business Wire	Carmila: Availability of documents for the Ordinary and Extraordinary Shareholder Meeting on 11 May 2023	NASDAQ:CARM	Carisma Therapeutics Inc
2023/04/20	22:22	Business Wire	Carmila : Modalités de mise à disposition ou de consultation des documents préparatoires à l’Assemblée Générale Mixte du 11 mai 2023	NASDAQ:CARM	Carisma Therapeutics Inc
2023/04/18	02:18	Business Wire	Carmila: New secured loan of EUR 276 million	NASDAQ:CARM	Carisma Therapeutics Inc
2023/04/18	02:18	Business Wire	Carmila : Signature d’un crédit hypothécaire de 276 millions d’euros	NASDAQ:CARM	Carisma Therapeutics Inc
2023/04/15	01:51	PR Newswire (US)	Carisma Therapeutics to Present at The American Association for Cancer Research Annual Meeting	NASDAQ:CARM	Carisma Therapeutics Inc
2023/04/07	05:30	PR Newswire (US)	Carisma Therapeutics to Present at Upcoming Healthcare Industry and Investor Conferences in April 2023	NASDAQ:CARM	Carisma Therapeutics Inc
2023/04/07	01:48	Business Wire	Carmila : Communiqué de mise à disposition du Document d’enregistrement universel 2022	NASDAQ:CARM	Carisma Therapeutics Inc
2023/04/07	01:48	Business Wire	Carmila: Filing of the 2022 Universal Registration Document	NASDAQ:CARM	Carisma Therapeutics Inc
2023/04/06	00:45	Business Wire	CARMILA : Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L.233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des marchés financiers	NASDAQ:CARM	Carisma Therapeutics Inc
2023/04/06	00:45	Business Wire	CARMILA: Information Concerning the Total Number of Voting Rights and Share	NASDAQ:CARM	Carisma Therapeutics Inc
2023/04/04	21:30	PR Newswire (US)	Carisma Therapeutics Reports Fiscal 2022 Financial Results and Recent Business Highlights	NASDAQ:CARM	Carisma Therapeutics Inc